One in four patients with secondary breast cancer had to visit…
https://i2.wp.com/www.cignpost.com/wp-content/uploads/2019/02/Add-heading-5.jpg?fit=1200%2C628&ssl=16281200https://www.cignpost.com/wp-content/uploads/2017/12/Cignpost.svg2019-10-21 14:51:232019-10-21 14:51:23Unacceptable delays in diagnosing secondary breast cancer
Younger women with a family history of breast cancer should receive…
https://i2.wp.com/www.cignpost.com/wp-content/uploads/2019/02/Add-heading-5.jpg?fit=1200%2C628&ssl=16281200https://www.cignpost.com/wp-content/uploads/2017/12/Cignpost.svg2019-02-13 12:34:442019-02-13 12:34:44Scan younger women at risk of breast cancer, charity says
The National Institute for Health and Care Excellence (NICE)…
https://i1.wp.com/www.cignpost.com/wp-content/uploads/2017/11/iStock-635475308-1.jpg?fit=724%2C483&ssl=1483724https://www.cignpost.com/wp-content/uploads/2017/12/Cignpost.svg2017-11-17 15:27:082017-11-17 15:27:08'Breakthrough' breast cancer drugs get NICE recommendation
https://i2.wp.com/www.cignpost.com/wp-content/uploads/2019/02/Add-heading-5.jpg?fit=1200%2C628&ssl=1
628
1200
https://www.cignpost.com/wp-content/uploads/2017/12/Cignpost.svg
2019-10-21 14:51:232019-10-21 14:51:23Unacceptable delays in diagnosing secondary breast cancer
https://i1.wp.com/www.cignpost.com/wp-content/uploads/2017/11/iStock-635475308-1.jpg?fit=724%2C483&ssl=1
483
724
https://www.cignpost.com/wp-content/uploads/2017/12/Cignpost.svg
2017-11-17 15:27:082017-11-17 15:27:08'Breakthrough' breast cancer drugs get NICE recommendation